fda semaglutide shortage resolved february 2025 announcement Novo's Wegovy and Ozempic removed from US list, compounders on notice FDA declares Wegovy® and Ozempic®

Our weight loss center has helped thousands of patients throughout the Houston area achieve meaningful and sustainable weight loss through comprehensive medical supervision and ongoing support

Figure 1 Table 1 Clinical timeline of oral semaglutide-associated depression, antidepressant management, and rechallenge

Side Effects Both medications have similar side effect profiles

Review: GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research

Slower titration reduces both the severity and duration of side effects

These insights hold significant implications for clinicians and policymakers tasked with managing T2DM effectively